BMS-986463
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986463, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. [Phase 1]